Delivery Order SPE2DB20D3101-SPE2DB21FK6J9

Award Date 9/23/21
Potential Completion Date 9/24/21
Potential Value $4.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II vaccine vials to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $76,697.60, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $43,492.00 and is a firm fixed-price Delivery Order that runs through April 21, 2023. The contract was awarded on April 20, 2023 and does not have a set-aside designation,...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a Defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,837.56 and a completion date of March 20, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of M-M-R II vaccine vials to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, which is a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD) that supports military healthcare programs. The contract has a ceiling value of...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,757.74. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 20, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The $2,782.65 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 5, 2024. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,722.10 with a firm fixed price. The contract has an ultimate completion date of November 1, 2024. This award is not associated with any set-aside requirements. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The $99,344.00 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,175.56 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is January 9, 2025. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK6J9
    Delivery Order

This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $4,283.44, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:10 AM